LabCorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.

Human Immunodeficiency Virus

Human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) remain leading causes of illness and death in the United States. The CDC has established guidelines for patients in all health care settings and pregnant women:1

For patients in all health care settings

  • HIV screening is recommended for patients in all health care settings after the patient is notified that testing will be performed unless the patient declines (opt-out screening)
  • Persons at high risk for HIV infection should be screened for HIV at least annually
  • Separate written consent for HIV testing should not be required; general consent for medical care should be considered sufficient to encompass consent for HIV testing
  • Prevention counseling should not be required with HIV diagnostic testing or as part of HIV screening programs in health-care settings

For pregnant women

  • HIV screening should be included in the routine panel of prenatal screening tests for all pregnant women
  • HIV screening is recommended after the patient is notified that testing will be performed unless the patient declines (opt-out screening)
  • Separate written consent for HIV testing should not be required; general consent for medical care should be considered sufficient to encompass consent for HIV testing
  • Repeat screening in the third trimester is recommended in certain jurisdictions with elevated rates of HIV infection among pregnant women

LabCorp’s fourth generation HIV antigen/antibody assay is available with a CDC-recommended supplemental algorithm.

Algorithm HIV

Fourth-generation HIV screening and associated supplemental testing is a valuable addition to the HIV screening tools especially for use in the high-risk populations where it will have its greatest impact. Detection of acute infections using the fourth-generation HIV screening assay provides an opportunity for early therapeutic intervention and the potential to reduce transmission rates.

For more information, please download the following brochures:

HIV 1/O/2 Cascade (4th generation) Technical Review   HIV Test Selection

LabCorp offers a wide range of HIV testing options.

Reference

  1. Centers for Disease Control and Prevention (CDC). Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-care Settings. Sept 22, 2006/55(RR14);1-17. Available at: ttps://www.cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm